{"id":"W2512837168","doi":"10.1016/j.jid.2016.06.075","title":"058 Efficacy of ixekizumab therapy: integrated analysis of 3 double-blind, controlled trials UNCOVER-1, UNCOVER-2, UNCOVER-3","year":2016,"lang":"en","type":"article","venue":"Journal of Investigative Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Ixekizumab; Medicine; Placebo; Etanercept; Psoriasis; Internal medicine; Double blind; Dosing; Clinical trial; Dermatology; Secukinumab; Pathology; Tumor necrosis factor alpha","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006818634,0.001988831,0.005969537,0.0009317256,0.0004742709,0.001829133,0.0008469636,0.001992116,0.003409629],"category_scores_gemma":[0.004894464,0.0008277585,0.008238003,0.0008805672,0.001421815,0.001603932,0.0006197114,0.002341582,0.0005897324],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009386417,"about_ca_system_score_gemma":0.001083403,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007046443,"about_ca_topic_score_gemma":0.001346314,"domain_scores_codex":[0.9952722,0.002760438,0.0004299159,0.000716091,0.0004745298,0.0003466892],"domain_scores_gemma":[0.9952396,0.00192378,0.00153684,0.0005998937,0.0003183788,0.0003813762],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.9594515,0.001760225,0.002281439,0.001099155,0.01361877,0.00002319444,0.00003878553,0.0005253102,0.002539836,0.00006634318,0.000364749,0.01823066],"study_design_scores_gemma":[0.8722226,0.0871764,0.01730515,0.0001681949,0.01918526,0.0000800181,0.00005790307,0.0009188073,0.001185659,0.000305242,0.001325248,0.00006950383],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9628466,0.02505901,0.00254819,0.0005333709,0.0004102258,0.002782268,0.003645012,0.0002590891,0.001916256],"genre_scores_gemma":[0.9876041,0.004862093,0.002142896,0.0005440957,0.0003334699,0.001269593,0.002060786,0.00005950106,0.001123412],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006818634,"threshold_uncertainty_score":0.03606081,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07545429452531802,"score_gpt":0.3149114856996707,"score_spread":0.2394571911743527,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}